TITLE

GPs have 'unhealthy' relationship with reps

PUB. DATE
June 2003
SOURCE
Pulse;6/2/2003, Vol. 63 Issue 22, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the criticism of journal 'BMJ' on the relationship between pharmaceutical industry and general practitioners on drug prescription consequences for patients in Great Britain.
ACCESSION #
10026468

 

Related Articles

  • Money-saving tips for dispensers. Phipps, Jeremy // GP: General Practitioner;2/13/2009, p53 

    The article offers practical tips for general practitioners (GPs) to cut cost on drug dispensing in England. One is to ensure that dispensers would not phone through orders. Another is to join a larger buying group for better discounts. GPs are also advised to monitor electricity, gas and other...

  • PCT curbs GPs' pharma links. Crump, Helen // Pulse;2/1/2007, Vol. 67 Issue 4, p12 

    The article reports on the urge of the Cambridgeshire Primary Care Trust for general practitioners (GPs) to limit their links with pharmaceutical companies in England. GP principals were required to get manager's consent before allowing sponsorship of meetings by drug companies. The new policy...

  • Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey. Vancelik, Serhat; Beyhun, Nazim E.; Acemoglu, Hamit; Calikoglu, Oksan // BMC Public Health;2007, Vol. 7 Issue 1, p122 

    Background: Commercial sources of information are known to have greater influence than scientific sources on general practitioners' (GPs) prescribing behavior in under developed and developing countries. The study aimed to determine the self-reported impact of pharmaceutical promotion on the...

  • GPs reject drug waste criticism. Pedder, Cato // Pulse;5/24/2007, Vol. 67 Issue 20, p10 

    The article focuses on the rejection of general practitioners (GPs) concerning drug waste criticism in Great Britain. GPs responded angrily to the accusation due to their wasteful prescription, ramping up the pressure for switching to cheaper drugs. The National Health Service could save at...

  • Scottish GPs defend use of non-generic drugs. Ward, Seamus // Public Finance;10/08/99, p8 

    Reports on the efforts of the Scottish general practitioners to defend use of non-generic drugs before Great Britain's Accounts Commission. Increased proportion of generic drugs from 1992 to 1999; Problems with the supply of generics.

  • US junior doctors found to be ignorant of drug companies' tactics. Spurgeon, David // BMJ: British Medical Journal (International Edition);5/1/2004, Vol. 328 Issue 7447, p1032 

    Reports that only a small proportion of medical residency programs in the United States teach doctors how to deal with pressures from the pharmaceutical industry. Success of the pharmaceutical industry in influencing doctors' prescribing decisions; Need for doctors to be aware of the conflicts...

  • Electronic medical records could save lives. Anderson, Roger W. // Business Insurance;5/23/2005, Vol. 39 Issue 21, p9 

    The article informs that pharmaceutical manufacturers have no direct relationship with the patients who take their medicines and, as a result, no direct means of notifying users of any apparent dangers that may be identified after the fact. Likewise, physicians who prescribe medications for...

  • UK MPs say health institute's and GP's performance not so NICE.  // PharmacoEconomics & Outcomes News;1/26/2008, Issue 545, p2 

    The article reports that the marketing efforts of the pharmaceutical industry influence the prescribing habits of general practitioners (GP) in Great Britain. This was revealed by a report from the British Public Accounts Committee. In addition, the report noted that GP prefer to prescribed...

  • Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review. Spurling, Geoffrey K.; Mansfield, Peter R.; Montgomery, Brett D.; Lexchin, Joel; Doust, Jenny; Othman, Noordin; Vitry, Agnes I. // PLoS Medicine;Oct2010, Vol. 7 Issue 10, p1 

    Background: Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence prescribing,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics